⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QURE News
uniQure N.V.
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
accessnewswire.com
QURE
ROSEN, TOP RANKED TRIAL LAWYERS, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
accessnewswire.com
QURE
Pomerantz LLP Highlights Legal Filing Against uniQure N.V. – QURE
accessnewswire.com
QURE
uniQure N.V. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 13, 2026 to Discuss Your Rights – QURE
globenewswire.com
QURE
$QURE ALERT: uniQure N.V. Sued for Securities Law Violations; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm
globenewswire.com
QURE
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
QURE
uniQure N.V. (QURE) Class Action Lawsuit Filed by Kessler Topaz Meltzer & Check, LLP: Investors Face March 13, 2026, Deadline
prnewswire.com
QURE
QURE CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026 Ready to Announce with Confidence?
newsfilecorp.com
QURE
Form 8-K
sec.gov
QURE
uniQure Announces 2025 Financial Results and Provides Recent Company Updates
globenewswire.com
QURE